98%
921
2 minutes
20
Purpose: The purposes of this study were to investigate the efficacy of radiocolloid lymphoscintigraphy and of handheld gamma probe procedure for sentinel lymph node biopsy (SLNB) in papillary thyroid carcinoma (PTC) and to evaluate its results in clinical staging.
Materials And Methods: Sixty-five PTC consecutive patients entered the study. Patients underwent radiocolloid lymphoscintigraphy before surgery. Intraoperative sentinel lymph node (SLN) localization was performed using a handheld gamma probe. They were followed up at 2, 6 months, and yearly.
Results: SLN metastases were diagnosed in 52%. Fifty-one patients underwent ablative 131-I therapy. The mean Tireoglobulin level in N0 vs N1 cases was 2.2 ng/ml vs 4.73 (p = 0.03) and 0.68 vs 2.1 ng/ml (p = 0.005) before and after 131-I therapy, respectively.
Conclusions: In patients classified N0 by SLNB, ablative 131-I therapy could be avoided.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00423-008-0376-5 | DOI Listing |
Clin Oncol (R Coll Radiol)
August 2025
School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom. Electronic address:
Targeted radionuclide therapy (TRT) involves systemic administration of a radionuclide attached to a cancer-targeting moiety. It has been proven to be a promising approach for primary cancer and metastasis treatment with minimal damage to surrounding tissues. TRT integrates the precision of molecular targeting with the therapeutic efficacy of radiation.
View Article and Find Full Text PDFAnalyst
September 2025
State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, P. R. China.
Recently, radioactive pollutants have garnered significant attention within the realms of environmental science and public safety, such as nuclear energy (, uranium), radiation therapy (, I), and earthquake monitoring (, radon), exerting multifaceted impacts on human health and ecosystems. Therefore, the development of accurate detection technologies for key radioactive elements is of paramount importance and is also an important guarantee for ensuring public safety and comprehensively promoting harmonious coexistence between humans and nature. Luminescent probes represent a class of detection methods for radioactive elements, characterized by high sensitivity, simplicity, and visualization.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Department of Thyroid Breast Surgery, The Affiliated Yixing Hospital of Jiangsu University, Wuxi, China.
Human Immunodeficiency Virus (HIV)-induced immunosuppression represents a potential risk factor for tumorigenesis and cancer progression, though existing studies have not conclusively established the association between HIV infection and the proliferation/metastasis of papillary thyroid carcinoma (PTC). We present a rare case of a 26-year-old male patient who exhibited rapid cervical tumor enlargement with extensive high-burden lymphatic metastasis following HIV infection. Imaging examinations revealed a cystic-solid thyroid mass with multiple lymphadenopathies in bilateral cervical regions, mediastinum, and axillae.
View Article and Find Full Text PDFNucl Med Commun
September 2025
Functional Medical Imaging, Biomedical Imaging Sciences, Division of Advanced, Information Health Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Objective: The primary treatments for Graves' disease include antithyroid drugs (ATD), thyroidectomy, and iodine-131 (I-131) therapy. This study aimed to identify factors predicting treatment outcomes and the treatment period required to achieve euthyroidism after I-131 administration.
Methods: This study included 109 patients with Graves' disease who underwent I-131 therapy.
Front Endocrinol (Lausanne)
August 2025
Department of Nuclear Medicine, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China.
Objective: To examine the factors influencing I-refractory Graves' disease (GD) hyperthyroidism in patients, develop a nomogram prediction model, and conduct its validation.
Methods: A total of 272 hyperthyroidism patients who received initial I treatment at our hospital from January 2021 to January 2022 were randomly selected. Patients were divided into refractory hyperthyroidism group (92 cases) and non-refractory hyperthyroidism group (180 cases) based on whether they were cured after one course of I treatment.